DME Capital Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-149,052
Closed -$1.29M 40
2024
Q2
$1.29M Hold
149,052
0.06% 35
2024
Q1
$1.3M Buy
+149,052
New +$1.3M 0.06% 38